Tolerability	tolerability	O	O	O	O
of	of	O	O	O	O
nimesulide	nimesulide	O	O	OTHERS	I
and	and	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
NSAID-induced	nsaid-induced	O	O	O	O
urticaria/angioedema	urticaria/angioedema	O	O	O	O
.	.	O	O	O	O

Previous	previous	O	O	O	O
studies	studies	O	O	O	O
evaluated	evaluated	O	O	O	O
the	the	O	O	O	O
tolerance	tolerance	O	O	O	O
of	of	O	O	O	O
nimesulide	nimesulide	O	O	OTHERS	I
and	and	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
subjects	subjects	O	O	O	O
with	with	O	O	O	O
cutaneous	cutaneous	O	O	O	O
,	,	O	O	O	O
respiratory	respiratory	O	O	O	O
and	and	O	O	O	O
anaphylactoid	anaphylactoid	O	O	O	O
reactions	reactions	O	O	O	O
induced	induced	O	O	O	O
by	by	O	O	O	O
nonsteroidal	nonsteroidal	O	O	O	O
anti-inflammatory	anti-inflammatory	O	O	O	O
drugs	drugs	O	O	O	O
(	(	O	O	O	O
NSAIDs	nsaids	O	O	OTHERS	I
)	)	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
this	this	O	O	O	O
study	study	O	O	O	O
we	we	O	O	O	O
investigated	investigated	O	O	O	O
tolerability	tolerability	O	O	O	O
and	and	O	O	O	O
reliability	reliability	O	O	O	O
of	of	O	O	O	O
nimesulide	nimesulide	O	O	OTHERS	I
and	and	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
very	very	O	O	O	O
large	large	O	O	O	O
number	number	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
exclusive	exclusive	O	O	O	O
well-documented	well-documented	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
NSAID-induced	nsaid-induced	O	O	O	O
urticaria/angioedema	urticaria/angioedema	O	O	O	O
.	.	O	O	O	O

Furthermore	furthermore	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
evaluated	evaluated	O	O	O	O
whether	whether	O	O	O	O
some	some	O	O	O	O
factors	factors	O	O	O	O
have	have	O	O	O	O
the	the	O	O	O	O
potential	potential	O	O	O	O
to	to	O	O	O	O
increase	increase	O	O	O	O
the	the	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
reaction	reaction	O	O	O	O
to	to	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
nimesulide	nimesulide	O	O	OTHERS	I
.	.	O	O	O	O

A	a	O	O	O	O
single-placebo-controlled	single-placebo-controlled	O	O	O	O
oral	oral	O	O	O	O
challenge	challenge	O	O	O	O
procedure	procedure	O	O	O	O
with	with	O	O	O	O
nimesulide	nimesulide	O	O	OTHERS	I
or	or	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
was	was	O	O	O	O
applied	applied	O	O	O	O
to	to	O	O	O	O
829	829	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
NSAID-induced	nsaid-induced	O	O	O	O
urticaria/angioedema	urticaria/angioedema	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
total	total	O	O	O	O
of	of	O	O	O	O
75/829	75/829	O	O	O	O
(	(	O	O	O	O
9.4	9.4	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
patients	patients	O	O	O	O
experienced	experienced	O	O	O	O
reactions	reactions	O	O	O	O
to	to	O	O	O	O
nimesulide	nimesulide	O	O	OTHERS	I
or	or	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

Of	of	O	O	O	O
the	the	O	O	O	O
715	715	O	O	O	O
patients	patients	O	O	O	O
tested	tested	O	O	O	O
with	with	O	O	O	O
nimesulide	nimesulide	O	O	OTHERS	I
62	62	O	O	O	O
(	(	O	O	O	O
8.6	8.6	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
showed	showed	O	O	O	O
a	a	O	O	O	O
positive	positive	O	O	O	O
test	test	O	O	O	O
,	,	O	O	O	O
while	while	O	O	O	O
of	of	O	O	O	O
114	114	O	O	O	O
subjects	subjects	O	O	O	O
submitted	submitted	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
challenge	challenge	O	O	O	O
with	with	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
13	13	O	O	O	O
(	(	O	O	O	O
9.6	9.6	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
did	did	O	O	O	O
not	not	O	O	O	O
tolerate	tolerate	O	O	O	O
this	this	O	O	O	O
drug	drug	O	O	O	O
.	.	O	O	O	O

Furthermore	furthermore	O	O	O	O
,	,	O	O	O	O
18.28	18.28	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
patients	patients	O	O	O	O
with	with	O	O	O	O
a	a	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
chronic	chronic	O	O	O	O
urticaria	urticaria	O	DISEASE	OTHERS	I
and	and	O	O	O	O
11.8	11.8	O	O	O	O
%	%	O	O	O	O
of	of	O	O	O	O
subjects	subjects	O	O	O	O
with	with	O	O	O	O
an	an	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
NSAID-induced	nsaid-induced	O	O	O	O
urticaria/angioedema	urticaria/angioedema	O	O	O	O
or	or	O	O	O	O
angioedema	angioedema	O	DISEASE	OTHERS	I
alone	alone	O	O	O	O
(	(	O	O	O	O
with	with	O	O	O	O
or	or	O	O	O	O
without	without	O	O	O	O
chronic	chronic	O	O	O	O
urticaria	urticaria	O	DISEASE	OTHERS	I
)	)	O	O	O	O
resulted	resulted	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
intolerant	intolerant	O	O	O	O
to	to	O	O	O	O
alternative	alternative	O	O	O	O
drugs	drugs	O	O	O	O
.	.	O	O	O	O

Taken	taken	O	O	O	O
together	together	O	O	O	O
,	,	O	O	O	O
our	our	O	O	O	O
results	results	O	O	O	O
confirm	confirm	O	O	O	O
the	the	O	O	O	O
good	good	O	O	O	O
tolerability	tolerability	O	O	O	O
of	of	O	O	O	O
nimesulide	nimesulide	O	O	OTHERS	I
and	and	O	O	O	O
paracetamol	paracetamol	CHEMICALS	O	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
who	who	O	O	O	O
experienced	experienced	O	O	O	O
urticaria/angioedema	urticaria/angioedema	O	O	O	O
caused	caused	O	O	O	O
by	by	O	O	O	O
NSAIDs	nsaids	O	O	OTHERS	I
.	.	O	O	O	O

However	however	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
risk	risk	O	O	O	O
of	of	O	O	O	O
reaction	reaction	O	O	O	O
to	to	O	O	O	O
these	these	O	O	O	O
alternative	alternative	O	O	O	O
study	study	O	O	O	O
drugs	drugs	O	O	O	O
is	is	O	O	O	O
statistically	statistically	O	O	O	O
increased	increased	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
chronic	chronic	O	O	O	O
urticaria	urticaria	O	DISEASE	OTHERS	I
and	and	O	O	O	O
,	,	O	O	O	O
above	above	O	O	O	O
all	all	O	O	O	O
,	,	O	O	O	O
by	by	O	O	O	O
a	a	O	O	O	O
history	history	O	O	O	O
of	of	O	O	O	O
NSAID-induced	nsaid-induced	O	O	O	O
angioedema	angioedema	O	DISEASE	OTHERS	I
.	.	O	O	O	O

